Based on Harvard and Boston Children’s Hospital research, Nocion Therapeutics has raised $27m to develop drugs for pain and inflammation.
Nocion Therapeutics, a US-based developer of pain and inflammation drugs spun out of Harvard University and Boston Children’s Hospital, has officially launched with $27m in series A funding from investors co-led by F-Prime Capital Partners.
F-Prime Capital, which is part of financial services group Fidelity, co-led the round alongside venture capital firm Canaan, with participation from Partners Innovation Fund, a VC vehicle run by nonprofit healthcare system Partners Healthcare, and venture firm BioInnovation Capital.
Nocion aims to develop…
